HUM

Business Context and Reporting Period

Company: Humana Inc.
Filing Type: Form 10-Q (Quarterly Report)
Reporting Period: Quarter and six months ended June 30, 2000
Business Overview: Humana is a major health services company facilitating care delivery through HMOs and PPOs to approximately 5.8 million medical members. Operations are divided into two segments: Health Plan (large group, Medicare, Medicaid, TRICARE) and Small Group (under 100 employees, specialty benefits).

Key Financial Metrics

Note: 1999 figures include significant one-time charges ($90M medical expense) and gains ($12M asset sale) in Q1 1999. Adjusted 1999 medical expense ratio for six months was 84.7%.

Material Changes vs. Prior Period

• Revenue Growth: Premium revenues increased 8.3% in Q2 2000 and 7.9% for the six-month period, driven primarily by higher premium yields (12.0% commercial, 6.3% Medicare) despite a 4.6% decline in total medical membership due to pricing actions.
• Profitability: Net income decreased 32% in Q2 2000 compared to Q2 1999 ($19M vs $28M). However, for the six-month period, net income increased 233% ($40M vs $12M) due to the absence of the $90M one-time medical expense charge recorded in Q1 1999.
• Cost Trends: Commercial pharmacy cost trends improved significantly to 7.4% in Q2 2000 from 18.8% in Q2 1999, attributed to the conversion of members to a three-tier pharmacy benefit plan.
• Membership: Total medical membership declined to 5.79 million in Q2 2000 from 6.07 million in Q2 1999. Small Group commercial membership dropped 13.0% due to attrition from price increases.

Guidance, Outlook, and Risks

Management Commentary & Strategy:

• Portfolio Optimization: Humana is actively exiting non-core businesses, including 45 Medicare counties and 17 small group commercial markets, to focus on profitable core segments.
• Divestitures: Completed sales of workers' compensation and North Florida Medicaid businesses; reinsured Medicare supplement business effective July 1, 2000. Net cash proceeds were $55 million for the six months ended June 30, 2000.
• Acquisitions: Acquired Memorial Sisters of Charity Health Network (MSCHN) for ~$50M and two shell entities for e-business and dental operations.
• Capital Allocation: Board authorized a $5 million share repurchase program; $16.8 million spent as of August 11, 2000.

Risks and Contingencies:

• Legislative Risk: Potential changes to Medicare reimbursement rates and Medicaid contracts could materially impact profitability.
• Regulatory Capital: Adoption of Risk-Based Capital (RBC) formulas by states may require an estimated $80 million capital infusion into subsidiaries.
• Litigation: Facing consolidated class action lawsuits regarding managed care practices (Price v. Humana) and provider payment disputes. Management believes these are without merit but outcomes are unpredictable.
• Accounting Changes: Goodwill amortization period reduced from 40 to 20 years, increasing annual amortization expense by $25 million.

Investor Verification Checklist

• Membership Attrition: Verify the sustainability of revenue growth given the 4.6% decline in total membership and 13% drop in Small Group members.
• Pharmacy Cost Trends: Confirm the durability of the improved pharmacy cost trends (7.4% vs 18.8%) following the three-tier plan conversion.
• Exit Strategy Execution: Monitor the financial impact of exiting 45 Medicare counties and 17 small group markets, specifically regarding higher-than-expected utilization in exiting Medicare counties.
• Regulatory Capital Requirements: Assess the potential need for the estimated $80 million capital infusion if states adopt RBC formulas without phase-in provisions.
• Litigation Exposure: Track the status of the consolidated class action litigation (Price v. Humana) and potential punitive damages not covered by insurance.